FORE Awards $2 Million in New Grants to Improve Access to
Funds to Provide Training, Address Stigma, and Develop Guidelines...
Globe Newswire8-03-2023, 23:17
Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide 8-10-2024, 13:35